The Diagnosis That Changes Which Treatment Even Makes Sense
A single patient treated for over a year for a diagnosis that may have never been the right one. The disagreement isn't between two drugs at all — it's about whether continuing to prescribe for the wrong mechanism can ever be the safer choice.
A.T., a 26-year-old veterinary technician, was diagnosed with gastroparesis fourteen months ago after recurrent postprandial regurgitation led her original gastroenterologist to order gastric emptying scintigraphy, which came back mildly delayed — a finding read at the time as sufficient explanation. Two prokinetic trials since, metoclopramide and then domperidone through the IND pathway, have done essentially nothing for her actual symptom, which she describes specifically as food coming back up effortlessly within minutes of eating, without nausea or retching beforehand, something she can often "just let happen" rather than something that overtakes her the way true vomiting does.
That specific detail — effortless, non-forceful regurgitation shortly after eating, without preceding nausea — is close to a diagnostic signature for rumination syndrome, not gastroparesis, and the two conditions are frequently confused because they share overlapping symptoms and because a genuinely mild gastric-emptying delay, present here, doesn't rule rumination out; the two conditions aren't mutually exclusive, and a mild GES abnormality can be a coincidental finding rather than the actual driver of her symptom. Her symptom onset followed a stressful veterinary board exam period, which fits the corrected picture rather than the original one: rumination syndrome frequently emerges or worsens around periods of psychological stress — not proof of the diagnosis on its own, but a piece of history that fits the corrected picture more coherently than it ever fit a pure motility explanation. Rumination syndrome is a learned, largely unconscious behavioral pattern: postprandial increases in intra-abdominal pressure, generated by an inappropriately timed diaphragmatic contraction, push gastric contents retrograde into the esophagus — a mechanical, behavioral event, not a motility failure, which is exactly why fourteen months of prokinetic therapy aimed at a motility problem she may not actually have has gone nowhere. Diaphragmatic breathing therapy, a specific behavioral technique that trains a patient to consciously counter the postprandial diaphragmatic contraction driving the reflux event, has real trial support: Halland and colleagues' manometry-based study found the technique corrects the abnormal gastroesophageal pressure gradient that drives rumination, making it the first-line, most mechanistically direct treatment for confirmed disease — a genuinely different category of intervention from anything pharmacologic, and the reason getting the diagnosis right here matters more than choosing between two drugs.
Correcting a diagnosis fourteen months in
The way she describes this — food coming back up effortlessly, within minutes, no nausea beforehand, something she can almost let happen rather than something that overtakes her — is close to a textbook description of rumination syndrome, not gastroparesis.
Rumination is a learned, largely unconscious behavioral pattern: a postprandial diaphragmatic contraction raises intra-abdominal pressure and pushes gastric contents back up. It's mechanical and behavioral, not a motility failure, which is exactly why two separate prokinetic trials, both reasonable choices for gastroparesis, haven't touched her symptom at all.
I find the symptom-pattern argument genuinely persuasive, and I agree the diagnosis likely needs correcting.
What gives me pause about stopping prokinetic therapy entirely is that her GES is still objectively abnormal, on two separate measurements now. It may well be coincidental rather than causal — the two conditions aren't mutually exclusive — but I'd rather not simply discard a confirmed finding on the assumption it's contributing nothing.
That's a reasonable caution, and I won't claim the GES finding is definitely irrelevant — only that it hasn't explained her actual symptom pattern despite two real pharmacologic attempts built around it.
I'd refer her for diaphragmatic breathing therapy as the primary treatment now, and agree to leaving low-dose prokinetic therapy in place in parallel rather than stopping everything at once — with a plan to taper it specifically if breathing therapy resolves her regurgitation on its own, which would be the clearest evidence yet about how much the GES finding was really contributing.
Referral placed for diaphragmatic breathing therapy as the primary treatment, with low-dose metoclopramide continued in parallel rather than stopped immediately, and an explicit plan to taper the prokinetic specifically if her regurgitation resolves once breathing therapy takes effect.
Agreed on the plan; the corrected diagnosis itself, more than the prokinetic-taper detail, was the real outcome of this consultation — fourteen months of treatment aimed at the wrong mechanism finally reframed around one that actually matches what she describes.